News Sentiment

ROIV sentiment intelligence

Roivant Sciences Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 60 Balanced news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 31.43 Week of 19 Jun 2026
Weighted tone 60/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

73/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+4.6% over one week, +4.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

What Roivant Sciences (ROIV)'s $2.25 Billion Moderna Settlement and Immunology Wins Mean For Shareholders

Market Reaction

Price moving ahead of tone

68/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 73/100 classification
One-week reaction 4.6% Price confirming higher
Trend fit Trend active 4.9% over four weeks
Fair value 117.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 30
Neutral 22
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
MarketBeat 6
Investing.com 5
Insider Monkey 4
simplywall.st 4
Simply Wall Street 3
TradingKey 3
Moomoo 3

Event Lens

What the news is about

Classified themes
Earnings 21
Market update 18
Analyst action 12
Balance sheet 2
Deals and strategy 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55